News
GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.
The layoffs will heavily affect Vertex’s operations in Rhode Island, where the biotech will consolidate three facilities into ...
T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 ...
WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...
Abbott is cranking up the innovation dial with a new partnership alongside Tandem Diabetes, aiming to reshape diabetes ...
5h
Medindia on MSNDiabetes Drug Semaglutide Linked to Vision Loss RiskGLP-1 RA use was linked to a 2.21-fold risk of developing neovascular age-related macular degeneration// (nAMD) * Only 0.2% ...
Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...
An estimated 38.1 million adults in the United States had diagnosed diabetes in 2021, according to the Centers for Disease ...
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...
During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results